Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Mar;83(3):757–763. doi: 10.1172/JCI113954

A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.

B G Bolscher 1, R van Zwieten 1, I M Kramer 1, R S Weening 1, A J Verhoeven 1, D Roos 1
PMCID: PMC303744  PMID: 2537848

Abstract

The NADPH:O2 oxidoreductase (NADPH oxidase) of human neutrophils is converted from a dormant to an active state upon stimulation of the cells. We have studied the soluble fraction that is required for NADPH oxidase activation in a cell-free system. Human neutrophils were separated in a membrane-containing and a soluble fraction. The soluble fraction was separated on carboxymethyl (CM) Sepharose in 10 mM 4-morpholino-ethanesulfonic acid buffer of pH 6.8. Reconstitution of the NADPH oxidase activity, measured as O2 consumption, was only found when the membrane fraction was combined with the flowthrough of the CM Sepharose column as well as with a fraction that eluted at 125 mM NaCl. This result indicates that at least two soluble components are necessary for reconstitution of the NADPH oxidase activity: one that does not bind to CM Sepharose and one that does bind. These components were designated soluble oxidase component (SOC) I and SOC II, respectively. Boiling destroyed the activity in both fractions. In the soluble fraction of human lymphocytes and thrombocytes neither SOC I nor SOC II activity was found. SOC II copurified with a 47-kD phosphoprotein, previously found defective in patients with the autosomal form of chronic granulomatous disease (CGD). Inactive soluble fractions of cells from autosomal CGD patients were reconstituted with a SOC II fraction from control cells. The result of this experiment indicates that autosomal CGD patients are normal in SOC I but defective in SOC II.

Full text

PDF
757

Images in this article

760Image
on p.760
760Image
on p.760
761Image
on p.761
761Image
on p.761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973 Mar;52(3):741–744. doi: 10.1172/JCI107236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Babior B. M., Kuver R., Curnutte J. T. Kinetics of activation of the respiratory burst oxidase in a fully soluble system from human neutrophils. J Biol Chem. 1988 Feb 5;263(4):1713–1718. [PubMed] [Google Scholar]
  3. Baehner R. L., Nathan D. G. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science. 1967 Feb 17;155(3764):835–836. doi: 10.1126/science.155.3764.835. [DOI] [PubMed] [Google Scholar]
  4. Borregaard N., Tauber A. I. Subcellular localization of the human neutrophil NADPH oxidase. b-Cytochrome and associated flavoprotein. J Biol Chem. 1984 Jan 10;259(1):47–52. [PubMed] [Google Scholar]
  5. Bourne H. R. GTP-binding proteins. One molecular machine can transduce diverse signals. 1986 Jun 26-Jul 2Nature. 321(6073):814–816. doi: 10.1038/321814a0. [DOI] [PubMed] [Google Scholar]
  6. Bromberg Y., Pick E. Activation of NADPH-dependent superoxide production in a cell-free system by sodium dodecyl sulfate. J Biol Chem. 1985 Nov 5;260(25):13539–13545. [PubMed] [Google Scholar]
  7. Curnutte J. T. Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system. J Clin Invest. 1985 May;75(5):1740–1743. doi: 10.1172/JCI111885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Curnutte J. T., Berkow R. L., Roberts R. L., Shurin S. B., Scott P. J. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation. J Clin Invest. 1988 Feb;81(2):606–610. doi: 10.1172/JCI113360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curnutte J. T., Kuver R., Babior B. M. Activation of the respiratory burst oxidase in a fully soluble system from human neutrophils. J Biol Chem. 1987 May 15;262(14):6450–6452. [PubMed] [Google Scholar]
  10. Curnutte J. T., Kuver R., Scott P. J. Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process. J Biol Chem. 1987 Apr 25;262(12):5563–5569. [PubMed] [Google Scholar]
  11. Figdor C. G., Bont W. S., De Vries J. E., Van Es W. L. Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique. J Immunol Methods. 1981;40(3):275–288. doi: 10.1016/0022-1759(81)90359-8. [DOI] [PubMed] [Google Scholar]
  12. Fujita I., Takeshige K., Minakami S. Characterization of the NADPH-dependent superoxide production activated by sodium dodecyl sulfate in a cell-free system of pig neutrophils. Biochim Biophys Acta. 1987 Oct 22;931(1):41–48. doi: 10.1016/0167-4889(87)90048-6. [DOI] [PubMed] [Google Scholar]
  13. Gabig T. G., English D., Akard L. P., Schell M. J. Regulation of neutrophil NADPH oxidase activation in a cell-free system by guanine nucleotides and fluoride. Evidence for participation of a pertussis and cholera toxin-insensitive G protein. J Biol Chem. 1987 Feb 5;262(4):1685–1690. [PubMed] [Google Scholar]
  14. Gennaro R., Florio C., Romeo D. Activation of protein kinase C in neutrophil cytoplasts. Localization of protein substrates and possible relationship with stimulus-response coupling. FEBS Lett. 1985 Jan 28;180(2):185–190. doi: 10.1016/0014-5793(85)81068-1. [DOI] [PubMed] [Google Scholar]
  15. Girard P. R., Mazzei G. J., Wood J. G., Kuo J. F. Polyclonal antibodies to phospholipid/Ca2+-dependent protein kinase and immunocytochemical localization of the enzyme in rat brain. Proc Natl Acad Sci U S A. 1985 May;82(9):3030–3034. doi: 10.1073/pnas.82.9.3030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hamers M. N., de Boer M., Meerhof L. J., Weening R. S., Roos D. Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease. Nature. 1984 Feb 9;307(5951):553–555. doi: 10.1038/307553a0. [DOI] [PubMed] [Google Scholar]
  17. Hayakawa T., Suzuki K., Suzuki S., Andrews P. C., Babior B. M. A possible role for protein phosphorylation in the activation of the respiratory burst in human neutrophils. Evidence from studies with cells from patients with chronic granulomatous disease. J Biol Chem. 1986 Jul 15;261(20):9109–9115. [PubMed] [Google Scholar]
  18. Heyworth P. G., Segal A. W. Further evidence for the involvement of a phosphoprotein in the respiratory burst oxidase of human neutrophils. Biochem J. 1986 Nov 1;239(3):723–731. doi: 10.1042/bj2390723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Holmes B., Page A. R., Good R. A. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest. 1967 Sep;46(9):1422–1432. doi: 10.1172/JCI105634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kikkawa U., Takai Y., Minakuchi R., Inohara S., Nishizuka Y. Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties. J Biol Chem. 1982 Nov 25;257(22):13341–13348. [PubMed] [Google Scholar]
  21. Kramer I. M., Verhoeven A. J., van der Bend R. L., Weening R. S., Roos D. Purified protein kinase C phosphorylates a 47-kDa protein in control neutrophil cytoplasts but not in neutrophil cytoplasts from patients with the autosomal form of chronic granulomatous disease. J Biol Chem. 1988 Feb 15;263(5):2352–2357. [PubMed] [Google Scholar]
  22. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  23. Lutter R., van Schaik M. L., van Zwieten R., Wever R., Roos D., Hamers M. N. Purification and partial characterization of the b-type cytochrome from human polymorphonuclear leukocytes. J Biol Chem. 1985 Feb 25;260(4):2237–2244. [PubMed] [Google Scholar]
  24. Markert M., Glass G. A., Babior B. M. Respiratory burst oxidase from human neutrophils: purification and some properties. Proc Natl Acad Sci U S A. 1985 May;82(10):3144–3148. doi: 10.1073/pnas.82.10.3144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McPhail L. C., Shirley P. S., Clayton C. C., Snyderman R. Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor. J Clin Invest. 1985 May;75(5):1735–1739. doi: 10.1172/JCI111884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Parkinson J. F., Akard L. P., Schell M. J., Gabig T. G. Cell-free activation of phagocyte NADPH-oxidase: tissue and differentiation-specific expression of cytosolic cofactor activity. Biochem Biophys Res Commun. 1987 Jun 30;145(3):1198–1204. doi: 10.1016/0006-291x(87)91564-6. [DOI] [PubMed] [Google Scholar]
  27. Roos D., Voetman A. A., Meerhof L. J. Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol. 1983 Aug;97(2):368–377. doi: 10.1083/jcb.97.2.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rossi F. The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta. 1986 Nov 4;853(1):65–89. doi: 10.1016/0304-4173(86)90005-4. [DOI] [PubMed] [Google Scholar]
  29. SBARRA A. J., KARNOVSKY M. L. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 1959 Jun;234(6):1355–1362. [PubMed] [Google Scholar]
  30. Segal A. W., Heyworth P. G., Cockcroft S., Barrowman M. M. Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein. Nature. 1985 Aug 8;316(6028):547–549. doi: 10.1038/316547a0. [DOI] [PubMed] [Google Scholar]
  31. Seifert R., Schultz G. Reversible activation of NADPH oxidase in membranes of HL-60 human leukemic cells. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1296–1302. doi: 10.1016/0006-291x(87)90790-x. [DOI] [PubMed] [Google Scholar]
  32. Vasilov R. G., Hahn A., Mölders H., van Rood J. J., Breuning M., Ploegh H. L. Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens. Immunogenetics. 1983;17(4):333–356. doi: 10.1007/BF00372454. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES